Product Categories
| Country: | China |
|---|---|
| Tel: | 021-18017925 |
| Mobile: | +8618916360931 |
| E-mail: | 2596183085@qq.com |
| QQ: | 2596183085 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| RX-3117 | C10H12FN3O4 | 865838-26-2 | Details |
| MAC13243 HCl | C20H25Cl2N3O2S | 1071638-38-4 | Details |
| ORM-10103 | C20H16N2O4 | 488847-28-5 | Details |
| TRAF-STOP inhibitor 6877002 | C17H17NO | 433249-94-6 | Details |
| MMP13-IN-3 | C24H22N4O5 | 1222173-37-6 | Details |
| Elenbecestat | C19H18F3N5O2S | 1388651-30-6 | Details |
| Piperidolate | C21H25NO2 | 82-98-4 | Details |
| Clobetasone butyrate | C26H32ClFO5 | 25122-57-0 | Details |
| Glucocorticoid receptor agonist-1 | C35H39NO6 | 2166375-82-0 | Details |
| Itepekimab | 2226742-52-3 | Details |
| NMDAR/TRPM4-IN-2 | C11H18BrClN2 | 2243506-33-2 | Details |
| USP1-IN-2 | C26H22F4N6O | 2098212-05-4 | Details |
| HHS-0701 | C20H20N4O3S | 2851993-91-2 | Details |
| Seviteronel R enantiomer | C18H17F4N3O3 | 1375603-38-5 | Details |
| Azido-PEG11-alcohol | C22H45N3O11 | 2252392-53-1 | Details |
| Navamepent | C18H24O4 | 1251537-11-7 | Details |
| Yadanzioside A | C32H44O16 | 95258-15-4 | Details |
| Ralaniten triacetate | C27H33ClO8 | 1637573-04-6 | Details |
| GSK3186899 | C19H28F3N7O3S | 1972617-87-0 | Details |
| GPR40/FFAR1 modulator 1 | C21H19N5O3 | 874755-26-7 | Details |
| Inebilizumab | 1299440-37-1 | Details |
| RORγt inverse agonist 13 | C23H17Cl2F3N2O4 | 2170477-75-3 | Details |
| GSK329 | C19H14Cl2F3N5O2 | 1268490-12-5 | Details |
| ABBV-318 | C20H15F4N3O2 | 1802848-94-7 | Details |
| Clofoctol | C21H26Cl2O | 37693-01-9 | Details |
| R1487 | C19H18F2N4O3 | 449811-92-1 | Details |
| Bullatine A | C22H33NO2 | 1354-84-3 | Details |
| GSK2324 | C29H22Cl2N2O4 | 1020567-30-9 | Details |
| Aplindore Fumarate | C22H22N2O7 | 189681-71-8 | Details |
| CAY10464 | C15H12Cl2O | 688348-37-0 | Details |
| G6Pase catalytic subunit 1 inhibitor 1 | C20H19N3 | 237402-29-8 | Details |
| ASK1-IN-2 | C19H17FN6O | 2541792-70-3 | Details |
| CDK12-IN-5 | C18H15F5N8O | 2651200-35-8 | Details |
| LB-60-OF61 | C29H30N6O2 | 794461-93-1 | Details |
| Gepotidacin mesylate dihydrate | C25H32N6O6S | 1624306-20-2 | Details |
| Magainin 2 | C114H180N30O29S | 108433-95-0 | Details |
| DS-3801b | C28H39N3O3 | 1369412-66-7 | Details |
| Tremelimumab | 745013-59-6 | Details |
| Spiroxatrine | C22H25N3O3 | 1054-88-2 | Details |
| N-[2-(diethylamino)ethyl]-2-iodobenzamide | C13H19IN2O | 170794-62-4 | Details |
| Tebanicline hydrochloride | C9H12Cl2N2O | 203564-54-9 | Details |
| EHT 1610 | C18H14FN5O2S | 1425945-60-3 | Details |
| SHP389 | C23H29ClN8O2 | 2235394-90-6 | Details |
| 12-Ketodeoxycholic acid | C24H38O4 | 5130-29-0 | Details |
| SRD5A1-IN-1 | C17H11F6NO3 | 2279077-93-7 | Details |
| Yadanzioside G | C36H48O18 | 95258-17-6 | Details |
| 16,17-Epoxypregnenol | C21H30O3 | 974-23-2 | Details |
| Farglitazar | C34H30N2O5 | 196808-45-4 | Details |
| Landipirdine | C18H19FN2O3S | 1000308-25-7 | Details |
| Aucuparin | C14H14O3 | 3687-28-3 | Details |
| Avelumab | 1537032-82-8 | Details |
| ATC 0175 hydrochloride | C23H25F2N5O.ClH | 510733-97-8 | Details |
| D-Mannopyranose | C6H12O6 | 530-26-7 | Details |
| Niraxostat | C16H17N3O3 | 206884-98-2 | Details |
| MK-0686 | C22H19ClF4N2O4 | 578727-68-1 | Details |
| JNJ-54175446 | C18H13ClF4N6O | 1627902-21-9 | Details |
| (R)-CR8 trihydrochloride | C24H30ClN7O | 1786438-30-9 | Details |
| SHMT-IN-1 | C18H16Cl2N4O | 1508286-18-7 | Details |
| BN201 | C25H38FN5O4 | 1361200-34-1 | Details |
| 6'-GNTI dihydrochloride | C27H30ClN5O3 | 2410327-94-3 | Details |
| Palmitoyl glutamic acid | C21H39NO5 | 38079-66-2 | Details |
| CDK9-IN-12 | C21H19ClN4O | 1942843-54-0 | Details |
| DPP-IV-IN-2 | C18H26N4O5 | 136259-18-2 | Details |
| Eflucimibe | C29H43NO2S | 202340-45-2 | Details |
| Necroptosis-IN-1 | C12H10ClN3O2 | 1391980-92-9 | Details |
| Budiodarone tartrate | C31H37I2NO11 | 478941-93-4 | Details |
| Z26395438 | C17H15FN2O | 2803-63-6 | Details |
| Thalidomide 4'-oxyacetamide-alkyl-C2-amine HCl | C17H19ClN4O6 | 2341841-02-7 | Details |
| D-Glucosamic acid | C6H13NO6 | 3646-68-2 | Details |
| ZW4864 free base | C33H42N6O3 | 2632259-92-6 | Details |
| Ripisartan | C23H22N8O | 148504-51-2 | Details |
| Hemipyocyanine | C12H8N2O | 528-71-2 | Details |
| ETRB Antagonist 1 | C22H18ClN5O4S | 290815-30-4 | Details |
| L-161240 | C15H20N2O5 | 183298-68-2 | Details |
| γ-Glu-Gly | C7H12N2O5 | 1948-29-4 | Details |
| Benalaxyl | C20H23NO3 | 71626-11-4 | Details |
| (S,R,S)-AHPC-PEG4-N3 | C32H47N7O8S | 1797406-81-5 | Details |
| ERK1/2 inhibitor 1 | C29H32ClN5O4 | 2095719-90-5 | Details |
| Mc-Val-Cit-PAB-Cl | C28H39ClN6O6 | 1639351-92-0 | Details |
| CGRP antagonist 1 | C29H26N4O4 | 1123757-49-2 | Details |
| Duloxetine | C18H19NOS | 116539-59-4 | Details |
| 4',6,7-Trimethoxyisoflavone | C18H16O5 | 798-61-8 | Details |
| Motilin (26-47), human, porcine | C120H188N34O35S | 52906-92-0 | Details |
| Resistomycin | C22H16O6 | 20004-62-0 | Details |
| Cedirogant | C24H20Cl3F3N2O3 | 2055496-11-0 | Details |
| (-)-JNJ-A07 | C28H26ClF3N2O6 | 2135640-92-3 | Details |
| Nebentan potassium | C24H22KN5O5S | 342005-82-7 | Details |
| SARS-CoV-2 Mpro-IN-2 | C22H20Cl2N4O2S | 2768834-39-3 | Details |
| Yadanzioside C | C34H46O17 | 95258-16-5 | Details |
| DAO-IN-1 | C7H5NO2S | 51856-25-8 | Details |
| Ophiopojaponin C | C44H70O18 | 911819-08-4 | Details |
| CCR2 antagonist 5 | C22H25F3N4O3S | 1228650-83-6 | Details |
| MK-0249 | C23H24F3N3O2 | 862309-06-6 | Details |
| GNE-5729 | C17H10Cl2F3N5O | 2026635-66-3 | Details |
| USP30 inhibitor 11 | C17H16N6O2S | 2067332-64-1 | Details |
| Raclopride | C15H20Cl2N2O3 | 84225-95-6 | Details |
| Fresolimumab | 948564-73-6 | Details |
| Abrilumab | 1342290-43-0 | Details |
| TNF-α-IN-2 | C25H21ClF2N6O | 2074702-04-6 | Details |
| Pumecitinib | C17H20N8O2S | 2401057-12-1 | Details |
| Product Total： Product Page： | ||||
| 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 | ||||